Form 6-K NOVARTIS AG For: Oct 27
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
Novartis Q3 preview: BofA sees strong product momentum, potential EBIT Upgrade
October 27, 2025 4:00 PM EDTNovartis (NYSE: NVS) is set to report third-quarter results that Bank of America expects will be broadly in line with consensus, underpinned by strong prescription trends for key growth drivers.
According to BofA analyst Sachin Jain, the Neutral-rated drugmakers Q3 earnings per share are forecast at $2.30, up 12% year-on-year, on sales of about $14... More
